article thumbnail

At Long Last, FDA Unveils Plan for Rare Disease Innovation Hub

FDA Law

This individual will play a key role in overseeing the new integrated Hub model and helping to develop and implement its strategic agenda action plan. those reviewed by the CDER Division of Rare Diseases and Medical Genetics). By Sarah Wicks & James E. Valentine & Frank J.

article thumbnail

Infectious Disease Board Meeting Summary | Spring 2025

ABIM

This is now being reviewed by the American Board of Medical Specialties, which oversees ABIM. In 2024, 75% of infectious disease physicians who chose an assessment opted for the LKA over the traditional, 10-year MOC exam. Society guests departed at this point in the meeting.